Integrated expression profiling of potassium channels identifys KCNN4 as a prognostic biomarker of pancreatic cancer
Integrated expression profiling of potassium channels identifys KCNN4 as a prognostic biomarker of pancreatic cancer
复制标题
钾通道的整合表达谱将 KCNN4 确定为胰腺癌的预后生物标志物
DOI:
10.1016/j.bbrc.2017.10.072
复制
发表时间:
2017-12-09
影响因子:
3.1
通讯作者:
Zhang, Zhigang
中科院分区:
文献类型:
--
作者:
Jiang, Shuheng;Zhu, Lili;Zhang, Zhigang
Dysregulated potassium (K+) channels have previously been shown to promote the development and progression of many types of cancers. Meanwhile, channels are particularly important in regulating the endocrine and exocrine functions of pancreas. However, the expression pattern and prognostic significance of K+ channels in pancreatic ductal adenocarcinoma (PDAC) remain unknown. In this study, by screening a GEO dataset containing 36 microdissected PDAC and matching normal pancreatic tissue samples, four differentially expressed K+ channels (KCNJ5, KCNJ16, KCNN4 and KCNK1) were identified in PDAC. by immunohistochemical analysis of tissue sections from Pdx1-(C) under bar re; LSL-(K) under bar ras(G12D /+) mice (KC), Pdx1-(C) under bar re; LSL-(K) under bar ras(G12D/+); LSL-Tr (P) under bar 53(R172H/+) mice (KPC) and human PDAC tissue microarrays, we found that Ca2+-activated K+ channel KCNN4 was significantly elevated in pancreatic intraepithelial neoplasia (PanIN) and PDAC epithelia compared with untransformed pancreas tissues. Higher epithelial KCNN4 expression was closely correlated with advanced TNM stages and predicted a poor prognosis in patients with PDAC. Elevated KCNN4 expression was significantly associated with shorter survival in univariable and multivariable analyses. Collectively, the identification of expression pattern of K+ channels in PDAC and its precursor PanIN demonstrates the importance of KCNN4 channel during the malignant transformation of PDAC. On the basis of the prognostic signals from two independent cohorts, KCNN4 should be considered as a promising therapeutic target. (C) 2017 Elsevier Inc. All rights reserved.